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HTLV-1 is the etiological agent of an aggressive malig-
nancy of the CD4+ T-cells, called adult T-cell leukemia
(ATL) and of certain other severe clinical disorders. The
viral Tax protein is a key factor in HTLV-1 pathogenicity.
A major part of Tax oncogenic potential is accounted for
by its capacity of inducing the transcriptional activity of
the NF-kB factors, which regulate the expression of
numerous cellular genes. Persistent activity of NF-kB
factors has been proved to play a central role in the patho-
physiology of ATL and other clinical disorders. PE, a nat-
ural product produced by honeybees, has been used for
long time in folk medicine. One of its active components,
caffeic acid phenethyl ester (CAPE), was found to be a
potent inhibitor of NF-kB activation. The main aim of this
project was to pursue the possibility of blocking all Tax
oncogenic effects in the cytoplasm and the nucleus, by
treatment with these products. The cells were transected
with a plasmid expressing Tax protein and plasmids con-
taining the examined promoters. Our results showed that
both PE and CAPE substantially inhibited the activation of
NF-kB-dependent promoter by Tax. However, only PE
could efficiently inhibit also the activation of SRF- and
CREB- dependent promoters by Tax. Also, both tested
materials strongly inhibited Tax binding to IkBa and b
and prevented their induced phosphorylation and degrada-
tion by Tax. However, they were not able to prevent Tax
or of NF-kB transport to the nucleus. In addition, only PE
prevented NF-kB nuclear activities.
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